ADViRNA
Oligonucleotide design, synthesis, and screening for therapeutic pipelines
ADViRNA provides oligonucleotide design, synthesis, and screening services with proprietary chemical modifications and conjugation technologies for therapeutic siRNA and ASO development.
Modalities
Development & manufacturing
Structured CDMO capabilities from verified public sources.
Development (D)
Manufacturing (M)
Services
About this organization
ADViRNA offers comprehensive contract research and manufacturing services for therapeutic oligonucleotides, including rational design, high-quality synthesis with chemical modifications, and comprehensive screening to identify effective candidates. The company provides siRNA reagents with self-deliverable RNAi technology for gene knockdown applications. Core capabilities include oligonucleotide conjugations, chemical modifications for enhanced stability and efficacy, and the proprietary HYBRID-ON™ oligonucleotide detection assay.
Related companies
Similar profiles by shared services, modalities, and capabilities.
atdbio- Oligonucleotide Manufacturing
- CMC Analytical Development
ChemGenes- Oligonucleotide Manufacturing
- CMC Analytical Development
LGC Biosearch Technologies- Oligonucleotide Manufacturing
- CMC Analytical Development
CPC Scientific- Oligonucleotide Manufacturing
- CMC Analytical Development
Sinopep-Allsino Biopharmaceutical Co., Ltd.- Oligonucleotide Manufacturing
- CMC Analytical Development
TriLink BioTechnologies- Oligonucleotide Manufacturing
- CMC Analytical Development
Porton- Oligonucleotide Manufacturing
- CMC Analytical Development
AM Chemicals LLC- Oligonucleotide
Submit a verified review for this organization.
Markdown mirror: /companies/advirna.md